RxDoctor Payments Data

Ryan Bennett, DO

Family Medicine · Topeka, KSNPI 1679782221

Payments from drug & device makers

$717in general payments, 2019–2025

Across 57 payments — averaging $12.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$196
  • Novo Nordisk$182
  • Sanofi-aventis U.S. LLC$38
  • Pfizer$35
  • Sunovion Pharmaceuticals Inc.$35
  • Boehringer Ingelheim$34
  • plus $197 from 13 others

What the payments were for

  • Food & beverage$69497%
  • Education$233%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$717 in reported general payments places this provider in the 55th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$110,437
Medicare patients
496
Services billed
1,802

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$36,984
EliquisApixaban41$29,550
MyrbetriqMirabegron22$14,141
FarxigaDapagliflozin Propanediol15$8,385
JanumetSitagliptin Phos/Metformin Hcl13$8,253
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$7,573
Levothyroxine Sodium364$2,795
Atorvastatin Calcium365$2,589
Arnuity ElliptaFluticasone Furoate11$2,462
Gabapentin143$2,095
Albuterol Sulfate HfaAlbuterol Sulfate51$1,689
Omeprazole253$1,478
Duloxetine Hcl31$1,426
Pantoprazole Sodium104$1,397
Losartan Potassium170$1,396

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$182$36,98425 claims
PfizerEliquis$35$29,55041 claims
Astellas Pharma US IncMyrbetriq$11$14,14122 claims
AstraZenecaFarxiga$11$8,38515 claims
GSKArnuity Ellipta$12$2,46211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Topeka

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →